Daniel Marechal
Direttore/Membro del Consiglio presso Targetome NV
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Eric Feller | M | - |
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 14 anni |
| Joseph Martial | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 anni |
| Domenico Petta | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 anni |
| Francesco Fornieri | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 anni |
| John Kelly | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Denis Hermesse | M | 54 |
University of Liege
| 4 anni |
| Jean-Marc Gilson | M | 60 |
University of Liege
| 1 anni |
| François Camille Gilbert van Uffelen | M | - |
University of Liege
| 1 anni |
| Stephane Berghmans | M | 55 |
University of Liege
| 3 anni |
| Denis Goffaux | M | 57 |
University of Liege
| 4 anni |
| Valérie Gordenne | F | 52 |
University of Liege
| 4 anni |
| Emmanuel Lacroix | M | - |
University of Liege
| 5 anni |
| Jean-Pierre Verlaine | M | - |
University of Liege
| 2 anni |
| Philippe Kolh | M | - |
University of Liege
| 4 anni |
| Nikkolaos Antimissaris | M | 55 |
University of Liege
| 4 anni |
| Valérie Renard | M | - |
University of Liege
| 4 anni |
| Dimitri Liquet | M | - |
University of Liege
| 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Belgio | 17 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Daniel Marechal
- Contatti personali
